2: Lecture 4 Flashcards

1
Q

How to decrease effects of aging

A

Caloric restriction, increase antioxidant uptake
Regular exercise
Decrease hormone fluctuations caused by decreased hormone production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does hormones change with age

A

Estrogen
Men–>steady linear decrease
Women–> large drop with menopause
Testosterone
Men and Women–>steady decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is menopause

A

Permanent cessation of menstruation resulting from loss of ovarian function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hormone changes before and after menopause

A

Before
*high levels of estrone and estradiol
*low levels of LH and FSH (inhibited by estrogen)
After
*Drop in levels of estrone, estradiol, and progesterone
*high levels of LH and FSH (no inhibition by estrogen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sources of estrogen before menopause

A

Estradiol is secretes and synthesized in ovaries
Estrone is produces in adipose tissue (stimulated by secretion of androstenedione from ovaries)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sources of estrogen after menopause

A

Estrone (produces in adipose tissue) is produced by androstenedione secreted from adrenal glands
Ovaries stop secreting estradiol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Type of estrogen receptors

A

1) Estrogen receptor alpha (ERalpha)
2) Estrogen receptor beta (ERbeta)
NOT isoforms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where does estrogen act

A

Brain, heart, liver, bones, and uterus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Progesterone receptor ISOFORMS

A

Product of alternative splicing
Progesterone receptor A (PR-A)
progesterone receptor B (PR-B)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Targets of progesterone action

A

CNS: Thermoregulation, sleep, EEG patterns
Systemic effects: protein and glucose metabolism, water and electrolyte metabolism
Uterus: progesterone protects against endometrial cancer
Mammary glands
hypothalamus and anterior pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Early symptoms of menopause

A

Hot flashes, insomnia, moodiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Intermediate symptoms of menopause

A

Vaginal atresia, bladder dysfunction, skin atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Late symptoms of menopause

A

Osteoporosis, cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risk of Estrogen therapy (ET)

A

Increased risk of endometrial cancer
Safe in patients without uterus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Use of Estrogen progestin therapy (EPT)

A

Decrease the chance of endometrial cancer in patients with a uterus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Benefits of hormone replacement therapy

A

Decrease in symptoms
Decrease in osteoporosis
Decrease in cardiovascular disease in women below 60 and within 10 years of menopause
Decrease in risk of colon cancer

17
Q

Risks of hormone replacement therapy

A

Increased risk of venous thrombosis, stroke, breast cancer, gallstones, dementia

18
Q

What is osteoporosis

A

Decrease in bone density that increase risk of bone fractures
Menopause accelerates the decrease in bone mass density
Estrogen has important role in regulation of bone remodeling

19
Q

How does Estrogen regulate bone remodeling?

A

High estrogen decrease production of RANKL (produced by osteoblasts)–>lower RANKL decreases osteoclast activity (breaking down bone)–>this increases osteoprotegerin that increases bone formation

20
Q

Non-pharmacologic treatments for osteoporosis prevention

A

Calcium and Vitamin D

21
Q

Pharmacologic treatment for osteoporosis prevention

A

Bisphosphonates (antiresorptive drug)
Selective estrogen receptor modulators (SERMS)

22
Q

Main action of Bisphosphonates

A

Inhibit osteoclast function and inhibit bone resorption

23
Q

Mechanism of Bisphosphonates

A

Nitrogen-containing bisphosphonates inhibit an enzyme in cholesterol biosynthesis pathway–>disrupts protein prenylation in osteoclasts–>creates cytoskeletal abnormalities in osteoclasts–>osteoclasts apoptosis
May increase risk of thigh bone fractures

24
Q

Where is ERalpha

A

Predominant estrogen receptor in female reproductive tract and breast

25
Q

Where is ERbeta

A

Predominant estrogen receptor in endothelial cells, bones, and prostate

26
Q

Main action of SERM (selective estrogen receptor modulator)

A

ex. bazedoxifene
Has antagonist action in breast and uterus AND agonist action in bone and lipid metabolism
SERMs can either activate or inhibit the receptors selectively
Overall increase bone density and decreases LDL

27
Q

Actions of ideal SERM (selective estrogen receptor modulator)

A

Strengthen bones, decrease LDL levels and increase HDL cholesterol levels, relive hot flashes, reduce breast cancer risk, reduce uterine cancer risk

28
Q

Major risk factors of cardiovascular disease

A

Hyperlipidemia (high lipid levels in the blood)
Atherosclerosis (cholesterol plaques in artery walls)

29
Q

How does estrogen effect cholesterol levels

A

Estrogen increases HDL levels
Estrogen decreases LDL levels
Estrogen also increases vascular dilation and decreases coronary artery LDL uptake

30
Q

What affects benefit/risk ratio of hormonal replacement therapy

A

The age when the patient starts treatment
Over 20 years after menopause–>HRT increase risk of cardiovascular disease
Less than 10 years after menopause–>no increase in risk of cardiovascular disease